Publications

5532 Results

A phase II study of IV bolus recombinant interleukin 2 in advanced malignant melanoma: A Southwest Oncology Group study.

Authors
RP Whitehead;KJ Kopecky;MK Samson;JJ Costanzi;RB Natale;LG Feun;EM Hersh;JJ Rinehart
Journal / Conference
JNCI 83(17):1250-1252
Year
1991
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8569

Phase II trial of recombinant DNA gamma interferon in advanced colorectal cancer: A Southwest Oncology Group study.

Authors
TD Brown;PJ Goodman;T Fleming;JS Macdonald;T O'Rourke;SA Taylor;JR Neefe;E Gaynor
Journal / Conference
Journal of Immunotherapy 10(5):379-382
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8630

Treatment of non-small cell lung cancer with vinblastine and very high dose cisplatin. A Southwest Oncology Group study.

Authors
SM Grunberg;JJ Crowley;RB Livingston;FM Muggia;JS Macdonald;SK Williamson;RL Stephens
Journal / Conference
Cancer Chemotherapy and Pharmacology 28:211-213
Year
1991
Research Committee(s)
Lung
Study Number(s)
SWOG-8703

Phase II evaluation of amonafide in renal cell carcinoma: A Southwest Oncology Group study.

Authors
CS Higano;P Goodman;JB Craig;JA Kish;SE Rivkin;B Blumenstein;ED Crawford
Journal / Conference
Investigational New Drugs 9:361-363
Year
1991
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8716

Evaluation of amonafide in refractory and relapsing multiple myeloma: A Southwest Oncology Group study.

Authors
KH Hanson;J Crowley;SE Salmon;M Keppen;TJ Braun;JD Bonnet
Journal / Conference
Anti-Cancer Drugs 2(3):247-250
Year
1991
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8726

A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer.

Authors
GT Budd;S Green;LH Baker;EP Hersh;JK Weick;CK Osborne
Journal / Conference
Cancer 68(8):1694-1695
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8741

Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.

Authors
GK Ellis;S Green;S Schulman;C Coltman, Jr;HE Hynes;S Rivkin;RB Livingston
Journal / Conference
Cancer 68(5):934-939
Year
1991
Research Committee(s)
Breast
Study Number(s)
SWOG-8748

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A Southwest Oncology Group study.

Authors
TD Brown;PJ Goodman;T Fleming;JS Macdonald;EM Hersh;TJ Braun
Journal / Conference
Journal of Immunotherapy 10:376-378
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8755

Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

Authors
JP Kuebler;B Metch;DE Schuller;M Keppen;HE Hynes
Journal / Conference
IND 9:373-374
Year
1991
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8912

Survival determinants in extensive stage non-small cell lung cancer. The Southwest Oncology Group experience.

Authors
KS Albain;JJ Crowley;M LeBlanc;RB Livingston
Journal / Conference
JCO 9(9):1618-1626
Year
1991